Potential benefits of intermittent bisphosphonate therapy in osteoporosis.
Daragon
Alain
A
Pouplin
Sophie
S
D000284:Administration, Oral; D001862:Bone Resorption / Q000188:drug therapy; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D016896:Treatment Outcome
D004164:Diphosphonates